Peijia Medical participated in JenaValve’s $100m series C round while L Catterton led Planted Foods’ series B extension, lifting it to $93m.
Public markets
Biocytogen Pharmaceuticals, a China-based antibody drug discovery platform developer backed by insurer China Life, has listed on the Hong Kong Stock Exchange’s Main Board. The company is set to secure about HK$471m ($60m) in net proceeds having issued nearly 21.8 million shares at HK$25.22 apiece.